间羟胺 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "间羟胺" in Chinese language version.

refsWebsite

Global rank Chinese rank

1^st place

4^th place

5^th place

2^nd place

23^rd place

447^th place

581^st place

low place

3,823^rd place

3,456^th place

low place

low place

6^th place

4^th place

aacnjournals.org

Kee VR. Hemodynamic pharmacology of intravenous vasopressors. Crit Care Nurse. Aug 2003, 23 (4): 79–82 [2024-03-30]. PMID 12961786. doi:10.4037/ccn2003.23.4.79. （原始内容存档于2019-08-16）.

Harrison DC, Chidsey CA, Braunwald E. Studies on the Mechanism of Action of Metaraminol (Aramine). Annals of Internal Medicine. September 1963, 59 (3): 297–305. PMID 14065947. doi:10.7326/0003-4819-59-3-297.

Kee VR. Hemodynamic pharmacology of intravenous vasopressors. Crit Care Nurse. Aug 2003, 23 (4): 79–82 [2024-03-30]. PMID 12961786. doi:10.4037/ccn2003.23.4.79. （原始内容存档于2019-08-16）.
Harrison DC, Chidsey CA, Braunwald E. Studies on the Mechanism of Action of Metaraminol (Aramine). Annals of Internal Medicine. September 1963, 59 (3): 297–305. PMID 14065947. doi:10.7326/0003-4819-59-3-297.
McDonald M, Santucci R. Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol.. Int Braz J Urol. 2004, 30 (2): 121–2. PMID 15703094. doi:10.1590/S1677-55382004000200007 .
Koga S, Shiraishi K, Saito Y. Post-traumatic priapism treated with metaraminol bitartrate: case report.. J Trauma. 1990, 30 (12): 1591–3. PMID 2258979. doi:10.1097/00005373-199012000-00029.

Injection : Aramine (Metaraminol Bitartrate) (PDF). U.S. Food and Drug Administration (FDA). [12 March 2022]. （原始内容存档 (PDF)于2022-10-22）.
ANDA Approval for Metaraminol (PDF). United States Food and Drug Administration. 24 August 2021 [13 August 2022]. （原始内容存档 (PDF)于2022-12-06）.

Kee VR. Hemodynamic pharmacology of intravenous vasopressors. Crit Care Nurse. Aug 2003, 23 (4): 79–82 [2024-03-30]. PMID 12961786. doi:10.4037/ccn2003.23.4.79. （原始内容存档于2019-08-16）.
Harrison DC, Chidsey CA, Braunwald E. Studies on the Mechanism of Action of Metaraminol (Aramine). Annals of Internal Medicine. September 1963, 59 (3): 297–305. PMID 14065947. doi:10.7326/0003-4819-59-3-297.
McDonald M, Santucci R. Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol.. Int Braz J Urol. 2004, 30 (2): 121–2. PMID 15703094. doi:10.1590/S1677-55382004000200007 .
Koga S, Shiraishi K, Saito Y. Post-traumatic priapism treated with metaraminol bitartrate: case report.. J Trauma. 1990, 30 (12): 1591–3. PMID 2258979. doi:10.1097/00005373-199012000-00029.
Block T, Sturm W, Ernst G, Staehler G, Schmiedt E. [Metaraminol in therapy of various forms of priapism]. Urologe A. 1988, 27 (4): 225–9. PMID 3140463.

Injection : Aramine (Metaraminol Bitartrate) (PDF). U.S. Food and Drug Administration (FDA). [12 March 2022]. （原始内容存档 (PDF)于2022-10-22）.
Kee VR. Hemodynamic pharmacology of intravenous vasopressors. Crit Care Nurse. Aug 2003, 23 (4): 79–82 [2024-03-30]. PMID 12961786. doi:10.4037/ccn2003.23.4.79. （原始内容存档于2019-08-16）.
ANDA Approval for Metaraminol (PDF). United States Food and Drug Administration. 24 August 2021 [13 August 2022]. （原始内容存档 (PDF)于2022-12-06）.
Metaraminol 0.5 mg/ml, Solution for Injection in pre-filled syringe - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk. [2022-10-19]. （原始内容存档于2023-11-08）.
Metaraminol. Deranged Physiology. [2022-10-19]. （原始内容存档于2023-12-04）（英语）.